These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20861840)

  • 1. Is renal antiaging possible?
    Ito S
    Hypertens Res; 2010 Nov; 33(11):1110-1. PubMed ID: 20861840
    [No Abstract]   [Full Text] [Related]  

  • 2. Efonidipine improves renal function and decreases proteinuria in elderly hypertensive patients in the JATOS study.
    Okura T
    Hypertens Res; 2010 Nov; 33(11):1112-3. PubMed ID: 20811385
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine.
    Hayashi K; Saruta T; Goto Y; Ishii M;
    Hypertens Res; 2010 Nov; 33(11):1211-20. PubMed ID: 20844543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 5. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
    Koh KK; Quon MJ; Lee SJ; Han SH; Ahn JY; Kim JA; Chung WJ; Lee Y; Shin EK
    Diabetes Care; 2007 Jun; 30(6):1605-7. PubMed ID: 17351278
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihypertensive effects and pharmacokinetics of NZ-105 single administration in patients with hypertension].
    Yokoyama S; Kaburagi T; Mori N; Sakata K; Yoshida H; Hoshino T
    Nihon Jinzo Gakkai Shi; 1992 Feb; 34(2):199-205. PubMed ID: 1588771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal effects of combined anti-hypertensive treatments].
    Gallieni M; Olivi L; Mezzina N; Cozzolino M; Cusi D
    Recenti Prog Med; 2010 Feb; 101(2):70-7. PubMed ID: 20433005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of strict- and mild-blood pressure control in elderly hypertensive patients: a per-protocol analysis of JATOS.
    Rakugi H; Ogihara T; Goto Y; Ishii M;
    Hypertens Res; 2010 Nov; 33(11):1124-8. PubMed ID: 20686490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The message for World Kidney Day 2009: hypertension and kidney disease--a marriage that should be prevented.
    Bakris GL; Ritz E;
    J Hum Hypertens; 2009 Mar; 23(3):222-5. PubMed ID: 19158823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS).
    JATOS Study Group
    Hypertens Res; 2008 Dec; 31(12):2115-27. PubMed ID: 19139601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hypertension in renal parenchymal diseases].
    Iversen BM; Kvam FI; Svarstad E
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2022-6. PubMed ID: 8766645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertensive crisis and postcrisis management.
    Lowenthal DT
    Compr Ther; 1978 Dec; 4(12):32-9. PubMed ID: 738010
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of hypertension.
    Fogo A; Kon V
    Semin Nephrol; 1996 Nov; 16(6):555-66. PubMed ID: 9125800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril.
    Del Vecchio L; Pozzi M; Salvetti A; Maschio G; Fusaroli M; Rovati C; Antonucci F; Cascone C; Scanferla F; Panichi V; Sturani A; Locatelli F;
    J Nephrol; 2004; 17(2):261-9. PubMed ID: 15293527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathologic basis and treatment considerations in chronic kidney disease-related hypertension.
    Sica D; Carl D
    Semin Nephrol; 2005 Jul; 25(4):246-51. PubMed ID: 16202697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term effect of efonidipine therapy on plasma aldosterone and left ventricular mass index in patients with essential hypertension.
    Tsutamoto T; Tanaka T; Nishiyama K; Yamaji M; Kawahara C; Fujii M; Yamamoto T; Horie M
    Hypertens Res; 2009 Aug; 32(8):670-4. PubMed ID: 19498438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of combination antihypertensive therapy in the prevention and treatment of chronic kidney disease.
    Weir MR
    Am J Hypertens; 2005 Apr; 18(4 Pt 2):100S-105S. PubMed ID: 15837552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease.
    Apperloo AJ; de Zeeuw D; de Jong PE
    Kidney Int Suppl; 1994 Feb; 45():S174-8. PubMed ID: 8158890
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.